315 related articles for article (PubMed ID: 27364890)
1. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.
Sommer A; Fadler T; Dorfmeister E; Hoffmann AC; Xiang W; Winner B; Prots I
J Neuroinflammation; 2016 Jun; 13(1):174. PubMed ID: 27364890
[TBL] [Abstract][Full Text] [Related]
2. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.
Depboylu C; Stricker S; Ghobril JP; Oertel WH; Priller J; Höglinger GU
Exp Neurol; 2012 Dec; 238(2):183-91. PubMed ID: 22964486
[TBL] [Abstract][Full Text] [Related]
3. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
Gardai SJ; Mao W; Schüle B; Babcock M; Schoebel S; Lorenzana C; Alexander J; Kim S; Glick H; Hilton K; Fitzgerald JK; Buttini M; Chiou SS; McConlogue L; Anderson JP; Schenk DB; Bard F; Langston JW; Yednock T; Johnston JA
PLoS One; 2013; 8(8):e71634. PubMed ID: 24058406
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
6. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
George S; Tyson T; Rey NL; Sheridan R; Peelaerts W; Becker K; Schulz E; Meyerdirk L; Burmeister AR; von Linstow CU; Steiner JA; Galvis MLE; Ma J; Pospisilik JA; Labrie V; Brundin L; Brundin P
J Parkinsons Dis; 2021; 11(2):585-603. PubMed ID: 33579871
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
[TBL] [Abstract][Full Text] [Related]
8. miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.
Moore CS; Rao VT; Durafourt BA; Bedell BJ; Ludwin SK; Bar-Or A; Antel JP
Ann Neurol; 2013 Nov; 74(5):709-20. PubMed ID: 23818336
[TBL] [Abstract][Full Text] [Related]
9. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
[TBL] [Abstract][Full Text] [Related]
10. The role of Galectin-3 in α-synuclein-induced microglial activation.
Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
[TBL] [Abstract][Full Text] [Related]
12. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.
Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A
Front Immunol; 2019; 10():80. PubMed ID: 30761145
[TBL] [Abstract][Full Text] [Related]
14. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
[TBL] [Abstract][Full Text] [Related]
16. Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice.
Xu W; Qi Y; Gao Y; Quan H; Li Q; Zhou H; Huang J
Toxicol Appl Pharmacol; 2021 Sep; 427():115658. PubMed ID: 34332006
[TBL] [Abstract][Full Text] [Related]
17. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.
Christiansen JR; Olesen MN; Otzen DE; Romero-Ramos M; Sanchez-Guajardo V
J Neuroinflammation; 2016 Apr; 13(1):74. PubMed ID: 27055651
[TBL] [Abstract][Full Text] [Related]
19. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
Rocha EM; Smith GA; Park E; Cao H; Graham AR; Brown E; McLean JR; Hayes MA; Beagan J; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
Antioxid Redox Signal; 2015 Aug; 23(6):550-64. PubMed ID: 26094487
[TBL] [Abstract][Full Text] [Related]
20. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
